I know this is very frustrating...BUT...Based on this portion of the requested action: "If you believe that your products are not in violation of the FD&C Act, please include in your submission to us your reasoning and any supporting information for our consideration within 15 working days from the date of receipt of this letter."

Don't you think that CYDY's BOD and management would actually see this as an opportunity to actually explain the updated information that was reviewed in the video along with the supporting evidence?? Every expert that has reviewed and used the drug for Covid knows how effective it is (even if antidotal), and is aware of its outstanding historical safety profile. Hasn't much changed since Sept 2021? I would think that with the expertise of our legal team, and PR team that we could actually find a way to turn this "Lemon of a letter" into lemonade... especially in light of our Long-Covid results and upcoming results that we have and/ or hope to achieve in Brazil? Shouldn't we have the opportunity to show the evidence (even if hypothetical) that clearly shows why the drug was not approved (based on trail design and drug administration IV versus injection) and why the drug is actually proving to be safe and effective? I think we all know that even if a drug is not approved... it can still be safe and effective?